Literature DB >> 15529380

Criteria for steroid-sparing ability of interventions in systemic lupus erythematosus: report of a consensus meeting.

.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2004        PMID： 15529380     DOI： 10.1002/art.20599

Source DB:  PubMed          Journal:  Arthritis Rheum        ISSN： 0004-3591


× No keyword cloud information.
  10 in total

1.  Consensus treatment plans for induction therapy of newly diagnosed proliferative lupus nephritis in juvenile systemic lupus erythematosus.

Authors:  Rina Mina; Emily von Scheven; Stacy P Ardoin; B Anne Eberhard; Marilynn Punaro; Norman Ilowite; Joyce Hsu; Marisa Klein-Gitelman; L Nandini Moorthy; Eyal Muscal; Suhas M Radhakrishna; Linda Wagner-Weiner; Matthew Adams; Peter Blier; Lenore Buckley; Elizabeth Chalom; Gaëlle Chédeville; Andrew Eichenfield; Natalya Fish; Michael Henrickson; Aimee O Hersh; Roger Hollister; Olcay Jones; Lawrence Jung; Deborah Levy; Jorge Lopez-Benitez; Deborah McCurdy; Paivi M Miettunen; Ana I Quintero-del Rio; Deborah Rothman; Ornella Rullo; Natasha Ruth; Laura E Schanberg; Earl Silverman; Nora G Singer; Jennifer Soep; Reema Syed; Larry B Vogler; Ali Yalcindag; Cagri Yildirim-Toruner; Carol A Wallace; Hermine I Brunner
Journal:  Arthritis Care Res (Hoboken)       Date:  2012-03       Impact factor: 4.794

2.  Connective tissue disease: Trial of SLE therapies in real-world settings.

Authors:  Manuel Ramos-Casals; Munther A Khamashta
Journal:  Nat Rev Rheumatol       Date:  2012-02-07       Impact factor: 20.543

Review 3.  [Glucocorticoid therapy in collagen diseases diseases].

Authors:  L Unger; M Kayser; M Enderlein; K Manger; H Nüsslein
Journal:  Z Rheumatol       Date:  2005-04       Impact factor: 1.372

4.  Glucocorticoid use and factors associated with variability in this use in the Systemic Lupus International Collaborating Clinics Inception Cohort.

Authors:  Jayne Little; Ben Parker; Mark Lunt; John G Hanly; Murray B Urowitz; Ann E Clarke; Juanita Romero-Diaz; Caroline Gordon; Sang-Cheol Bae; Sasha Bernatsky; Daniel J Wallace; Joan T Merrill; Jill Buyon; David A Isenberg; Anisur Rahman; Ellen M Ginzler; Michelle Petri; Mary Anne Dooley; Paul Fortin; Dafna D Gladman; Kristjan Steinsson; Rosalind Ramsey-Goldman; Munther A Khamashta; Cynthia Aranow; Meggan Mackay; Graciela S Alarcón; Susan Manzi; Ola Nived; Andreas Jönsen; Asad A Zoma; Ronald F van Vollenhoven; Manuel Ramos-Casals; Guillermo Ruiz-Irastorza; Sung Sam Lim; Kenneth C Kalunian; Murat Inanc; Diane L Kamen; Christine A Peschken; Soren Jacobsen; Anca Askanase; Jorge Sanchez-Guerrero; Ian N Bruce
Journal:  Rheumatology (Oxford)       Date:  2018-04-01       Impact factor: 7.580

5.  Efficacy of rituximab (anti-CD20) for refractory systemic lupus erythematosus involving the central nervous system.

Authors:  Mikiko Tokunaga; Kazuyoshi Saito; Daisuke Kawabata; Yoshitaka Imura; Takao Fujii; Shingo Nakayamada; Shizuyo Tsujimura; Masao Nawata; Shigeru Iwata; Taeko Azuma; Tsuneyo Mimori; Yoshiya Tanaka
Journal:  Ann Rheum Dis       Date:  2006-11-15       Impact factor: 19.103

6.  Outcome of a glucocorticoid discontinuation regimen in patients with inactive systemic sclerosis.

Authors:  Michele Iudici; Serena Vettori; Barbara Russo; Veronica Giacco; Domenico Capocotta; Gabriele Valentini
Journal:  Clin Rheumatol       Date:  2016-05-17       Impact factor: 2.980

Review 7.  Biomarkers and updates on pediatrics lupus nephritis.

Authors:  Michael Bennett; Hermine I Brunner
Journal:  Rheum Dis Clin North Am       Date:  2013-07-16       Impact factor: 2.670

8.  Flares after hydroxychloroquine reduction or discontinuation: results from the Systemic Lupus International Collaborating Clinics (SLICC) inception cohort.

Authors:  Celline C Almeida-Brasil; John G Hanly; Murray Urowitz; Ann Elaine Clarke; Guillermo Ruiz-Irastorza; Caroline Gordon; Rosalind Ramsey-Goldman; Michelle Petri; Ellen M Ginzler; D J Wallace; Sang-Cheol Bae; Juanita Romero-Diaz; Mary Anne Dooley; Christine Peschken; David Isenberg; Anisur Rahman; Susan Manzi; Søren Jacobsen; Sam Lim; Ronald F van Vollenhoven; Ola Nived; Andreas Jönsen; Diane L Kamen; Cynthia Aranow; Jorge Sanchez-Guerrero; Dafna D Gladman; Paul R Fortin; Graciela S Alarcón; Joan T Merrill; Kenneth Kalunian; Manuel Ramos-Casals; Kristján Steinsson; Asad Zoma; Anca Askanase; Munther A Khamashta; Ian N Bruce; Murat Inanc; Michal Abrahamowicz; Sasha Bernatsky
Journal:  Ann Rheum Dis       Date:  2021-12-15       Impact factor: 27.973

9.  Predictors of Unsuccessful Hydroxychloroquine Tapering and Discontinuation: Can We Personalize Decision-Making in Systemic Lupus Erythematosus Treatment?

Authors:  Celline C Almeida-Brasil; Christian A Pineau; Evelyne Vinet; John G Hanly; Christine A Peschken; Ann E Clarke; Paul R Fortin; Michal Abrahamowicz; Sasha Bernatsky
Journal:  Arthritis Care Res (Hoboken)       Date:  2022-04-13       Impact factor: 5.178

10.  International Consensus for the Dosing of Corticosteroids in Childhood-Onset Systemic Lupus Erythematosus With Proliferative Lupus Nephritis.

Authors:  Nathalie E Chalhoub; Scott E Wenderfer; Deborah M Levy; Kelly Rouster-Stevens; Amita Aggarwal; Sonia I Savani; Natasha M Ruth; Thaschawee Arkachaisri; Tingting Qiu; Angela Merritt; Karen Onel; Beatrice Goilav; Raju P Khubchandani; Jianghong Deng; Adriana R Fonseca; Stacy P Ardoin; Coziana Ciurtin; Ozgur Kasapcopur; Marija Jelusic; Adam M Huber; Seza Ozen; Marisa S Klein-Gitelman; Simone Appenzeller; André Cavalcanti; Lampros Fotis; Sern Chin Lim; Rodrigo M Silva; Julia Ramírez- Miramontes; Natalie L Rosenwasser; Claudia Saad-Magalhaes; Dieneke Schonenberg-Meinema; Christiaan Scott; Clovis A Silva; Sandra Enciso; Maria T Terreri; Alfonso-Ragnar Torres-Jimenez; Maria Trachana; Sulaiman M Al-Mayouf; Prasad Devarajan; Bin Huang; Hermine I Brunner
Journal:  Arthritis Rheumatol       Date:  2022-01-04       Impact factor: 10.995
  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.